Biologics and Small Molecules for Patients with Concomitant Alopecia Areata and Vitiligo: A Review

The review discusses the use of biologics and small molecules for treating patients with both alopecia areata and vitiligo. It highlights the potential of JAK inhibitors, which have shown promise in managing these conditions due to their role in modulating immune pathways involved in both diseases. The authors emphasize the need for further research to better understand the efficacy and safety of these treatments in patients with concomitant alopecia areata and vitiligo, as current data is limited. The review does not provide specific study data or participant numbers, indicating a focus on summarizing existing literature and identifying gaps for future investigation.